These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 1177050

  • 1. Bone marrow imaging using 111In-citrate: 111In-kinetics in the pelvic region.
    Glaubitt DM, Schlüter IH, Haberland KU.
    J Nucl Med; 1975 Aug; 16(8):769-74. PubMed ID: 1177050
    [Abstract] [Full Text] [Related]

  • 2. [Studies on the distribution of hematopoietic bone marrow by bone marrow scintigraphy. III. The bone marrow scintigraphy with 111In-chloride (author's transl)].
    Fujimori K.
    Nihon Ketsueki Gakkai Zasshi; 1976 Apr; 39(2):131-7. PubMed ID: 1036859
    [No Abstract] [Full Text] [Related]

  • 3. [99mTc-sulfur-rhenium colloid and 111In-indium citrate in bone-marrow scintigraphy].
    Glaubitt D, Haberland K, Knoch K, Fejér FL, Zachariah S.
    Blut; 1975 Mar; 30(3):213-21. PubMed ID: 1122342
    [Abstract] [Full Text] [Related]

  • 4. Bone-marrow imaging in pure red blood cell aplasia.
    Bunn HF, McNeil BJ, Rosenthal DS, Krantz SB.
    Arch Intern Med; 1976 Oct; 136(10):1169-72. PubMed ID: 971017
    [Abstract] [Full Text] [Related]

  • 5. As bone marrow scintigraphy in patients treated with chemotherapy and/or radiotherapy.
    Brousil J, Foltýnová V, Vĕtrovcová E, Tichá E.
    Nuklearmedizin; 1977 Apr; 16(2):86-8. PubMed ID: 876848
    [Abstract] [Full Text] [Related]

  • 6. [Bone marrow scintigraphy in anemia caused by impaired hemopoiesis. Respective values of technetium colloids and indium-transferrin].
    Rain JD, Castro-Malaspina H, Dresch C, Najean Y.
    Nouv Presse Med; 1975 May 17; 4(20):1471-6. PubMed ID: 1215143
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of carcinoma of the cervix using 111In-bleomycin.
    Woolfenden JM, Waxman AD, Disaia PJ, Siemsen JK.
    Obstet Gynecol; 1975 Sep 17; 46(3):347-52. PubMed ID: 51490
    [Abstract] [Full Text] [Related]

  • 8. [RI cisternography with 111-In-DTPA].
    Tokuriki Y, Miwa Y, Murata T, Fukumitsu T, Matsumura T.
    No To Shinkei; 1976 Jun 17; 28(6):579-88. PubMed ID: 1036152
    [Abstract] [Full Text] [Related]

  • 9. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
    Murray JL, Rosenblum MG, Lamki L, Glenn HJ, Krizan Z, Hersh EM, Plager CE, Bartholomew RM, Unger MW, Carlo DJ.
    J Nucl Med; 1987 Jan 17; 28(1):25-33. PubMed ID: 3794809
    [Abstract] [Full Text] [Related]

  • 10. A comparison of 111In with 52Fe and 99mTc-sulfur colloid for bone marrow scanning.
    Merrick MV, Gordon-Smith EC, Lavender JP, Szur L.
    J Nucl Med; 1975 Jan 17; 16(1):66-8. PubMed ID: 1089139
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetic substantiation of the use of 111In-citrate in bone marrow studies].
    Korsunskiĭ VN, Tarasenko IuI, Koval'chuk ND, Kosheleva IIu, Popov VI.
    Med Radiol (Mosk); 1986 Jul 17; 31(7):48-52. PubMed ID: 3736386
    [Abstract] [Full Text] [Related]

  • 12. The value of autologous indium (111In)-labelled platelets in the diagnosis of renal transplant rejection.
    Fenech A, Smith FW, Power DA, MacLeod AM, Nicholls AJ, Edward N, Catto GR, Bennett B.
    Clin Nephrol; 1984 Apr 17; 21(4):220-2. PubMed ID: 6375924
    [Abstract] [Full Text] [Related]

  • 13. Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution.
    Carrasquillo JA, White JD, Paik CH, Raubitschek A, Le N, Rotman M, Brechbiel MW, Gansow OA, Top LE, Perentesis P, Reynolds JC, Nelson DL, Waldmann TA.
    J Nucl Med; 1999 Feb 17; 40(2):268-76. PubMed ID: 10025834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intraoperative bone and bone marrow sampling: a simple method for accurate measurement of uptake of radiopharmaceuticals in bone and bone marrow.
    Oyen WJ, Buijs WC, van Kampen A, Koenders EB, Claessens RA, Corstens FH.
    Nucl Med Commun; 1993 Feb 17; 14(2):112-6. PubMed ID: 8429988
    [Abstract] [Full Text] [Related]

  • 16. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
    Borchardt PE, Quadri SM, Freedman RS, Vriesendorp HM.
    J Nucl Med; 1998 Mar 17; 39(3):476-84. PubMed ID: 9529295
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapy.
    Shen S, Meredith RF, Duan J, Macey DJ, Khazaeli MB, Robert F, LoBuglio AF.
    J Nucl Med; 2002 Sep 17; 43(9):1245-53. PubMed ID: 12215566
    [Abstract] [Full Text] [Related]

  • 19. Letter: Splenic uptake of 111In.
    Vieras F.
    J Nucl Med; 1975 Dec 17; 16(12):1205-6. PubMed ID: 1194979
    [No Abstract] [Full Text] [Related]

  • 20. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
    Goodwin DA, Meares CF, McCall MJ, Haseman MK, McTigue M, Diamanti CI, Chaovapong W.
    J Nucl Med; 1985 May 17; 26(5):493-502. PubMed ID: 3921673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.